- Home
- HOWL vs PMVP Comparison
HOWL vs PMVP Comparison
Compare HOWL & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- PMVP
- Stock Information
- Founded
- HOWL 2017
- PMVP 2013
- Country
- HOWL United States
- PMVP United States
- Employees
- HOWL N/A
- PMVP N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- HOWL Health Care
- PMVP Health Care
- Exchange
- HOWL Nasdaq
- PMVP Nasdaq
- Market Cap
- HOWL 53.4M
- PMVP 55.1M
- IPO Year
- HOWL 2021
- PMVP 2020
- Fundamental
- Price
- HOWL $1.10
- PMVP $1.06
- Analyst Decision
- HOWL Strong Buy
- PMVP Strong Buy
- Analyst Count
- HOWL 3
- PMVP 1
- Target Price
- HOWL $8.33
- PMVP $5.00
- AVG Volume (30 Days)
- HOWL 648.5K
- PMVP 283.2K
- Earning Date
- HOWL 08-07-2025
- PMVP 08-07-2025
- Dividend Yield
- HOWL N/A
- PMVP N/A
- EPS Growth
- HOWL N/A
- PMVP N/A
- EPS
- HOWL N/A
- PMVP N/A
- Revenue
- HOWL $1,143,000.00
- PMVP N/A
- Revenue This Year
- HOWL N/A
- PMVP N/A
- Revenue Next Year
- HOWL N/A
- PMVP N/A
- P/E Ratio
- HOWL N/A
- PMVP N/A
- Revenue Growth
- HOWL N/A
- PMVP N/A
- 52 Week Low
- HOWL $0.60
- PMVP $0.81
- 52 Week High
- HOWL $4.18
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- HOWL 46.17
- PMVP 52.88
- Support Level
- HOWL $1.18
- PMVP $1.01
- Resistance Level
- HOWL $1.30
- PMVP $1.12
- Average True Range (ATR)
- HOWL 0.12
- PMVP 0.08
- MACD
- HOWL -0.03
- PMVP -0.00
- Stochastic Oscillator
- HOWL 6.33
- PMVP 23.26
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.